BSX — BOSTON SCIENTIFIC CORP
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 885725 ·
Last close
$43.03
Market Cap
$62.37B
52W High
$101.91
52W Low
$39.57
ADV30
18,457,961
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 5,203,000,000 | 3,613,000,000 | 1,072,000,000 | 1,341,000,000 | 44,351,000,000 | 1,453,000,000 | 18,247,000,000 |
| Dec 2025 | 5,286,000,000 | 3,678,000,000 | 1,041,000,000 | 672,000,000 | 43,673,000,000 | 1,965,000,000 | 19,201,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,102,000,000
Investing CF
$-2,040,000,000
Financing CF
$-1,118,000,000
CapEx
$-1,109,000,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$2.36
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$8,400,000,000
Inventory
$3,317,000,000
Receivables
$3,113,000,000
ST Investments
—
EBIT TTM
$3,901,000,000
Pretax Income TTM
$3,534,000,000
Interest Exp TTM
$367,000,000
Analysts
28
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,070,000,128
EBITDA
$5,569,999,872
Free Cash Flow
$2,491,875,072
Enterprise Value
$73,551,978,496
Total Cash
$609,000,000
Total Debt
$11,953,000,448
Shares Out
1,449,473,222
Trailing EPS
$2.37
Book Value
$17.68
ROE
14.1%
ROA
5.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 20,074,000,000 | 3,971,000,000 | 2,898,000,000 | 43,673,000,000 | 19,201,000,000 | 24,232,000,000 | 4,534,000,000 |
| Dec 2024 | 16,747,000,000 | 3,002,000,000 | 1,854,000,000 | 39,395,000,000 | 17,392,000,000 | 21,770,000,000 | 3,435,000,000 |
| Dec 2023 | 14,240,000,000 | 2,417,000,000 | 1,593,000,000 | 35,136,000,000 | 15,606,000,000 | 19,281,000,000 | 2,503,000,000 |
| Dec 2022 | 12,682,000,000 | 2,034,000,000 | 698,000,000 | 32,469,000,000 | 14,896,000,000 | 17,574,000,000 | 1,526,000,000 |
TTM Snapshot
Revenues TTM
$20,995,000,000
NetIncome TTM
$3,675,000,000
OpCashFlow TTM
—
Assets (Latest)
$45,216,000,000
Forward EPS
$3.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EW | Edwards Lifesciences Corp | $60.62B | $105.43 | — |
| BDX | BECTON DICKINSON & CO | $58.68B | $215.42 | — |
| MMM | 3M CO | $93.28B | $180.88 | — |
| GEHC | GE HealthCare Technologies Inc. | $37.00B | $81.84 | — |
| RMD | RESMED INC | $33.46B | $237.85 | — |
News headlines (Yahoo Finance, 1h cache)
Is Boston Scientific Still The Business You Bought?
2026-11-16 11:42 · Yahoo
Coherent and Boston Scientific have been highlighted as Zacks Bull and Bear of the Day
2026-11-13 12:27 · Yahoo
Bear of the Day: Boston Scientific (BSX)
2026-11-13 10:20 · Yahoo
U.S. Peripheral Liquid Embolic Agents Market Size, Share, Trends and Forecast (2026-2036) Featuring Profiles of Boston Scientific Corp., Terumo Medical Corp. (MicroVention), BlackSwan Vascular (Sirtex
2026-11-12 16:17 · Yahoo
Boston Scientific (BSX) Is Back In The Spotlight, What Is Driving Attention?
2026-11-12 11:10 · Yahoo
Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls?
2026-11-11 17:15 · Yahoo
Boston Scientific (BSX) Stock May Be 38% Undervalued Following WATCHMAN Trial News
2026-11-11 16:11 · Yahoo
Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027
2026-11-11 15:15 · Yahoo
A $52 Billion Fund Bought These 3 Stocks
2026-11-14 11:56 · Yahoo
What Heartflow (HTFL) Said on Its Q3 Earnings Call
2026-11-13 03:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.